ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

VYNE Stock Ownership Breakdown

NASDAQ : VYNE

VYNE Therapeutics Inc.

$2.19

-0.14-6.01%

Open: 4:00 PM

58.55

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

VYNE Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableYes

OptionableNo

Short Percent Of Outstanding Shares0.84

Short Percent Of Float0.84

Shares Outstanding14.75M

Shares Float10.07M

Shares Short123.20K

Short Ratio0.93

0.84%

Short % of Float

0.84%

Short % of Shares Outstanding

Market Insider VYNE

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

8.43% Percentage of Shares held by All Insiders

49.84% Percentage of Shares held by All Institutions

54.43% Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About 49.84% of VYNE shares are held by financial institutions. STALEY CAPITAL ADVISERS INC is the top corporate investor, holding 36.47K shares valued at $111.97K. A 0.35% stake in VYNE Therapeutics Inc. is owned by the company. CORNERSTONE PLANNING GROUP LLC owns 2 shares valued at $6.00, which translates its holding of 0% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
2024-03-31	STALEY CAPITAL ADVISERS INC	0.35%	36.47K	111.97K	0	0
2024-03-31	CORNERSTONE PLANNING GROUP LLC	0%	2	6	2	+100.00%
2023-12-31	STALEY CAPITAL ADVISERS INC	1.11%	36.47K	84.98K	13K	+55.39%

VYNE Insiders

Among the VYNE insiders holding of 8.43% of the stake in company, PERCEPTIVE ADVISORS LLC, 10 percent owner, holds the largest shares of 4.94M. REMEDITEX VENTURES LLC, 10 percent owner, is the second largest VYNE insider with ownership of 1.58M shares. DOMZALSKI DAVID, President and CEO, stands third with possession of 1.32M shares of that stake.

Insiders	Designation	Shares Held
PERCEPTIVE ADVISORS LLC	10 percent owner	4.94M
REMEDITEX VENTURES LLC	10 percent owner	1.58M
DOMZALSKI DAVID	President and CEO	1.32M
SAIK ANDREW	Chief Financial Officer	340K
VENBIO GLOBAL STRATEGIC FUND II L.P.	10 percent owner	265K
LEPORE PATRICK G	director	51.47K
PRESIDIO PARTNERS 2007 GP, L.P.		48.91K
VIVO CAPITAL VIII, LLC	10 percent owner	35.69K
CHA ALBERT	director	35.69K
HARSCH MUTYA	Chief Legal Officer and GC	22.72K

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
2025-01-15	LEPORE PATRICK G	PURCHASE	2.92	15K	43.8K	51.47K
2023-11-15	LEPORE PATRICK G	PURCHASE	3.91	13K	50.78K	36.47K
2023-03-20	LEPORE PATRICK G	PURCHASE	2.48	20K	49.68K	23.47K
2023-03-20	HARSCH MUTYA	PURCHASE	2.50	10K	25K	22.72K
2021-11-30	LEPORE PATRICK G	PURCHASE	1.02	12.5K	12.7K	62.5K
2021-08-25	LEPORE PATRICK G	PURCHASE	1.60	12.5K	20K	50K
2021-08-16	PERCEPTIVE ADVISORS LLC	SALE	1.74	250K	435K	4.94M
2021-08-13	PERCEPTIVE ADVISORS LLC	SALE	1.84	250K	460K	5.19M
2021-08-12	PERCEPTIVE ADVISORS LLC	SALE	2.23	338.9K	755.74K	5.44M
2021-05-26	LEPORE PATRICK G	PURCHASE	3.60	12.5K	44.96K	37.5K
2021-05-06	PERCEPTIVE ADVISORS LLC	SALE	3.67	1M	3.67M	5.77M
2021-03-15	LEPORE PATRICK G	PURCHASE	7.41	12.5K	92.56K	25K
2021-01-28	PERCEPTIVE ADVISORS LLC	PURCHASE	2.37	4.22M	10M	27.1M
2020-12-03	LEPORE PATRICK G	PURCHASE	1.71	50K	85.43K	50K
2020-09-08	SAIK ANDREW	PURCHASE	1.46	40K	58.48K	340K
2020-09-08	DOMZALSKI DAVID	PURCHASE	1.38	75K	103.57K	1.32M
2020-06-09	PERCEPTIVE ADVISORS LLC	PURCHASE	1.85	2.7M	5M	22.88M
2018-07-24	PRESIDIO PARTNERS 2007 GP, L.P.	SALE	7.65	12.5K	95.63K	48.91K
2018-01-25	VENBIO GLOBAL STRATEGIC FUND II L.P.	PURCHASE	17.00	265K	4.51M	265K
2018-01-25	REMEDITEX VENTURES LLC	PURCHASE	17.00	100K	1.7M	1.58M
2018-01-25	VIVO CAPITAL VIII, LLC	PURCHASE	17.00	35.69K	606.66K	35.69K
2018-01-25	CHA ALBERT	PURCHASE	17.00	35.69K	606.66K	35.69K

Insider Transaction Summary (6 Months)

SHARESTRANS

PURCHASE15K1

SALES00

NET SHARES15K1

NO. OF SHARES HELD51.47K1

% NET SHARES-70.86%0%

Frequently Asked Questions

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter